-
Roche Reveals Striking Data: 96% of Patients Did Not Relapse Within a Year, but Safety is in Doubt
Roche announced on September 4 the latest results from the Phase II FENopta Open Label Extension (OLE) study of the BTK inhibitor fenebrutinib.
2024-09-05 17:35 -
Boehringer Ingelheim Acquires SAH: A New Breakthrough in Animal Health or Expansion of Business Bubb...
The company has successfully acquired Saiba Animal Health (SAH), a company dedicated to the development of therapeutic vaccines aimed at addressing an...
2024-09-05 17:35 -
Safety of Novo Nordisk's Growth Hormone Injection Under Scrutiny: Weekly Dosing Raises New Concerns
Pasil auxin injection contains the active ingredient somapacitan, which is a long-acting variant of human growth hormone (hGH). Somapacitan modifies n...
2024-09-05 17:34 -
Olon acquires Huvepharma Italia
Olon continues its growth momentum and increases its total production capacity with the acquisition of Huvepharma Italia and its plant in Garessio, Cu...
2024-09-05 10:25 -
New Bladder Cancer Drug Vemurafenib Extends Survival by Over Half a Year, But Side Effects Occur in ...
Vientumab is indicated for the treatment of locally advanced or metastatic uroepithelial carcinoma in adult patients who have previously received plat...
2024-09-04 15:53 -
Aspen Pharmacare Reports Disappointing Results! Stock Plunges 13%, EBITDA Increases by Only 1% in Fu...
Despite this challenge, the company's positive expectations for GLP-1 pharmaceutical contracts will provide strong support for future profit growth. A...
2024-09-04 15:51 -
Pfizer Spends $43 Billion to Acquire Seagen, But Questions Arise as to Whether Its 8 New Drugs Can S...
Pfizer recently announced that it has completed the acquisition of Seagen, which specializes in antibody drug coupling agents (ADCs), for $43 billion.
2024-09-04 15:51 -
Mundipharma International's Chinese Subsidiary's Assets Sold at a Discount Failed, $1 Billion in Cas...
Pharmaceutical giant Mundipharma International, part of the world-renowned Sackler Family, has failed for the second time to find a suitable buyer for...
2024-09-03 17:42 -
Indonesia-Africa Forum Reveals $3.5 Billion in Business Contracts, but Measles Outbreak Casts Shadow...
The Indonesian president on Monday announced his country's intention to sign commercial contracts totaling $3.5 billion with African countries during ...
2024-09-03 17:41 -
Hundreds of Millions in Funding Flood into the lncRNA Field, Major Companies Bet on the ‘Zone of Li...
Under the agreement, the two companies will jointly develop two small molecule therapies targeting long non-coding Rnas (lncrnas), with the aim of fur...
2024-09-03 17:41
Hot News
- 关于进一步规范化学品信息发布、... Jan 27, 2026
- BASF’s 2025 Report Card—“Th... Jan 27, 2026
- Invista Reshuffles Global Nylo... Jan 28, 2026
- 5%–10% Is Just the Surface: B... Jan 15, 2026
- “Europe’s Chemical Industry ... Feb 02, 2026
Related Products


